Global Peptide Cancer Vaccine Market Research Report 2022 - Market Size, Current Insights and Development Trends

Publisher Name :
Date: 17-Jan-2023
No. of pages: 101

The report focuses on the Peptide Cancer Vaccine market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Peptide Cancer Vaccine market.

Major Players in the Peptide Cancer Vaccine market are:

OncoTherapy Science

Imugene

Ultimovacs

BrightPath Biotherapeutics

Sellas

ISA Pharmaceuticals

Immatics

Generex Biotechnology

VAXON Biotech

TapImmune

Boston Biomedical

On the basis of types, the Peptide Cancer Vaccine market is primarily split into:

Multivalent peptide vaccine

Peptide cocktail type

Personalized peptide vaccine

Peptide-pulsed dendritic cancer vaccine

Hybrid peptide vaccine

Others

On the basis of applications, the market covers:

Breast Cancer

Lung Cancer

Melanoma

Prostate Cancer

Others

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global Peptide Cancer Vaccine Market Research Report 2022 - Market Size, Current Insights and Development Trends

Table of Content

1 Peptide Cancer Vaccine Market Overview
1.1 Product Overview and Scope of Peptide Cancer Vaccine Market
1.2 Peptide Cancer Vaccine Market Segment by Type
1.2.1 Global Peptide Cancer Vaccine Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Peptide Cancer Vaccine Market Segment by Application
1.3.1 Peptide Cancer Vaccine Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Peptide Cancer Vaccine Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Peptide Cancer Vaccine (2017-2029)
1.5.1 Global Peptide Cancer Vaccine Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Peptide Cancer Vaccine Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Peptide Cancer Vaccine Industry
1.7 Impact of Carbon Neutrality on the Peptide Cancer Vaccine Industry

2 Peptide Cancer Vaccine Market Upstream and Downstream Analysis
2.1 Peptide Cancer Vaccine Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Peptide Cancer Vaccine Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 OncoTherapy Science
3.1.1 OncoTherapy Science Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Peptide Cancer Vaccine Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Imugene
3.2.1 Imugene Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Peptide Cancer Vaccine Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Ultimovacs
3.3.1 Ultimovacs Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Peptide Cancer Vaccine Market Performance (2017-2022)
3.3.4 Business Overview
3.4 BrightPath Biotherapeutics
3.4.1 BrightPath Biotherapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Peptide Cancer Vaccine Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Sellas
3.5.1 Sellas Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Peptide Cancer Vaccine Market Performance (2017-2022)
3.5.4 Business Overview
3.6 ISA Pharmaceuticals
3.6.1 ISA Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Peptide Cancer Vaccine Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Immatics
3.7.1 Immatics Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Peptide Cancer Vaccine Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Generex Biotechnology
3.8.1 Generex Biotechnology Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Peptide Cancer Vaccine Market Performance (2017-2022)
3.8.4 Business Overview
3.9 VAXON Biotech
3.9.1 VAXON Biotech Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Peptide Cancer Vaccine Market Performance (2017-2022)
3.9.4 Business Overview
3.10 TapImmune
3.10.1 TapImmune Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Peptide Cancer Vaccine Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Boston Biomedical
3.11.1 Boston Biomedical Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Peptide Cancer Vaccine Market Performance (2017-2022)
3.11.4 Business Overview

4 Global Peptide Cancer Vaccine Market Landscape by Player
4.1 Global Peptide Cancer Vaccine Sales and Share by Player (2017-2022)
4.2 Global Peptide Cancer Vaccine Revenue and Market Share by Player (2017-2022)
4.3 Global Peptide Cancer Vaccine Average Price by Player (2017-2022)
4.4 Global Peptide Cancer Vaccine Gross Margin by Player (2017-2022)
4.5 Peptide Cancer Vaccine Market Competitive Situation and Trends
4.5.1 Peptide Cancer Vaccine Market Concentration Rate
4.5.2 Peptide Cancer Vaccine Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global Peptide Cancer Vaccine Sales, Revenue, Price Trend by Type
5.1 Global Peptide Cancer Vaccine Sales and Market Share by Type (2017-2022)
5.2 Global Peptide Cancer Vaccine Revenue and Market Share by Type (2017-2022)
5.3 Global Peptide Cancer Vaccine Price by Type (2017-2022)
5.4 Global Peptide Cancer Vaccine Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Peptide Cancer Vaccine Sales, Revenue and Growth Rate of Multivalent peptide vaccine (2017-2022)
5.4.2 Global Peptide Cancer Vaccine Sales, Revenue and Growth Rate of Peptide cocktail type (2017-2022)
5.4.3 Global Peptide Cancer Vaccine Sales, Revenue and Growth Rate of Personalized peptide vaccine (2017-2022)
5.4.4 Global Peptide Cancer Vaccine Sales, Revenue and Growth Rate of Peptide-pulsed dendritic cancer vaccine (2017-2022)
5.4.5 Global Peptide Cancer Vaccine Sales, Revenue and Growth Rate of Hybrid peptide vaccine (2017-2022)
5.4.6 Global Peptide Cancer Vaccine Sales, Revenue and Growth Rate of Others (2017-2022)

6 Global Peptide Cancer Vaccine Market Analysis by Application
6.1 Global Peptide Cancer Vaccine Consumption and Market Share by Application (2017-2022)
6.2 Global Peptide Cancer Vaccine Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Peptide Cancer Vaccine Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Peptide Cancer Vaccine Consumption and Growth Rate of Breast Cancer (2017-2022)
6.3.2 Global Peptide Cancer Vaccine Consumption and Growth Rate of Lung Cancer (2017-2022)
6.3.3 Global Peptide Cancer Vaccine Consumption and Growth Rate of Melanoma (2017-2022)
6.3.4 Global Peptide Cancer Vaccine Consumption and Growth Rate of Prostate Cancer (2017-2022)
6.3.5 Global Peptide Cancer Vaccine Consumption and Growth Rate of Others (2017-2022)

7 Global Peptide Cancer Vaccine Sales and Revenue Region Wise (2017-2022)
7.1 Global Peptide Cancer Vaccine Sales and Market Share, Region Wise (2017-2022)
7.2 Global Peptide Cancer Vaccine Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global Peptide Cancer Vaccine Market Forecast (2022-2029)
8.1 Global Peptide Cancer Vaccine Sales, Revenue Forecast (2022-2029)
8.1.1 Global Peptide Cancer Vaccine Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Peptide Cancer Vaccine Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Peptide Cancer Vaccine Price and Trend Forecast (2022-2029)
8.2 Global Peptide Cancer Vaccine Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Peptide Cancer Vaccine Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Peptide Cancer Vaccine Sales and Revenue Forecast (2022-2029)
8.2.3 China Peptide Cancer Vaccine Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Peptide Cancer Vaccine Sales and Revenue Forecast (2022-2029)
8.2.5 India Peptide Cancer Vaccine Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Peptide Cancer Vaccine Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Peptide Cancer Vaccine Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Peptide Cancer Vaccine Sales and Revenue Forecast (2022-2029)
8.3 Global Peptide Cancer Vaccine Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Peptide Cancer Vaccine Revenue and Growth Rate of Multivalent peptide vaccine (2022-2029)
8.3.2 Global Peptide Cancer Vaccine Revenue and Growth Rate of Peptide cocktail type (2022-2029)
8.3.3 Global Peptide Cancer Vaccine Revenue and Growth Rate of Personalized peptide vaccine (2022-2029)
8.3.4 Global Peptide Cancer Vaccine Revenue and Growth Rate of Peptide-pulsed dendritic cancer vaccine (2022-2029)
8.3.5 Global Peptide Cancer Vaccine Revenue and Growth Rate of Hybrid peptide vaccine (2022-2029)
8.3.6 Global Peptide Cancer Vaccine Revenue and Growth Rate of Others (2022-2029)
8.4 Global Peptide Cancer Vaccine Consumption Forecast by Application (2022-2029)
8.4.1 Global Peptide Cancer Vaccine Consumption Value and Growth Rate of Breast Cancer (2022-2029)
8.4.2 Global Peptide Cancer Vaccine Consumption Value and Growth Rate of Lung Cancer (2022-2029)
8.4.3 Global Peptide Cancer Vaccine Consumption Value and Growth Rate of Melanoma (2022-2029)
8.4.4 Global Peptide Cancer Vaccine Consumption Value and Growth Rate of Prostate Cancer (2022-2029)
8.4.5 Global Peptide Cancer Vaccine Consumption Value and Growth Rate of Others (2022-2029)
8.5 Peptide Cancer Vaccine Market Forecast Under COVID-19

9 Industry Outlook
9.1 Peptide Cancer Vaccine Market Drivers Analysis
9.2 Peptide Cancer Vaccine Market Restraints and Challenges
9.3 Peptide Cancer Vaccine Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Peptide Cancer Vaccine Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Peptide Cancer Vaccine Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Peptide Cancer Vaccine Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source
  • Global BCG Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global BCG Vaccine market size was valued at US$ 365.6 million in 2023. With growing demand in downstream market, the BCG Vaccine is forecast to a readjusted size of US$ 542.8 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global BCG Vaccine market. BCG Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Peptide Cancer Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Peptide Cancer Vaccine market size was valued at US$ 535 million in 2023. With growing demand in downstream market, the Peptide Cancer Vaccine is forecast to a readjusted size of US$ 1978.2 million by 2030 with a CAGR of 20.5% during review period. The research report highlights the growth potential of the global Peptide Cancer Vaccine market. Peptide Cancer Vaccine are expected to show stable growth in the future market. How......
  • Global Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Cancer Vaccine market: According to our latest research, the global Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Cancer Vaccine market was estimated at USD 7198.2 million, and it's anticipated to reach USD 33936.62 million in 2028, with a CAGR of 29.49% during the forecast years. A cancer vaccine is a type of immunotherapy that boost the body's natural defenses by stimulating the immune system to recognize and cur......
  • Global Lung Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Lung Cancer Vaccines market: According to our latest research, the global Lung Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Lung Cancer Vaccines market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Lung Cancer Vaccines,A cancer vaccine for lung cance This report covers a research time span from 2018 to 2028, and ......
  • Global Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 105
    Market Overview of Global Cancer Vaccines market: According to our latest research, the global Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Cancer Vaccines market was estimated at USD 5773.14 million, and it's anticipated to reach USD 15406.41 million in 2028, with a CAGR of 17.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Vacci......
  • Global Dendritic Cell Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 110
    Market Overview of Global Dendritic Cell Cancer Vaccine market: According to our latest research, the global Dendritic Cell Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Dendritic Cell Cancer Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Dendritic cells (DC) are one of the major antigen presenting cells found in lymphoid organs. The main fu......
  • Global BCG Vaccine Market Research Report 2023, Forecast to 2028
    Published: 14-Nov-2023        Price: US 2680 Onwards        Pages: 135
    BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......
  • Global BCG Vaccine Professional Survey Report 2023, Forecast to 2028
    Published: 14-Nov-2023        Price: US 3280 Onwards        Pages: 105
    BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......
  • Infectious Vaccine Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300
    Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious vaccine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of infectious vaccine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter infectious vaccine deals. These deals tend to be multicomponent, starting with......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs